A 25-year-old Japanese man presented with high spiking fever, arthralgia and a skin rash. A pruritic edematous erythema with persistent plaques was found mainly on the trunk; these lesions persisted even when the fever subsided, with prominent linear pigmentation. As marked neutrophilia and a high level of serum ferritin were detected, a diagnosis of adult-onset Still’s disease (AOSD) was made, even though the persistent eruption was not characteristic of the disease. Oral prednisolone, together with low-dose methotrexate, was given with good results. In the literature, a similar atypical rash has been reported in 11 cases in Japan. All of them required high-dose administration of corticosteroids or other immunosuppressive agents. Severe systemic complications were seen in 3 patients, and 2 cases died of the disease. Persistent plaques and linear pigmentation are some of the manifestations of AOSD, which cannot be overlooked. This appearance could be an indication that suggests an increased risk of systemic complications and a prolonged time to clinical remission.

Keywords:
Still’s disease, adult-onset, Atypical skin rash, Linear pigmentation, Persistent plaque, Interleukin 6, Methotrexate
1.
Kaur S, Bambery P, Dhar S: Persistent dermal plaque lesions in adult-onset Still’s disease. Dermatology 1994;188:241–242.
2.
Setterfield JF, Hughes GR, Kobza Black A: Urticaria as a presentation of adult Still’s disease. Br J Dermatol 1998;138:906–908.
3.
Lübbe J, Hofer M, Chavaz P, Saurat JH, Borradori L: Adult-onset Still’s disease with persistent plaques. Br J Dermatol 1999;141:710–713.
4.
Yamaguchi M, Ohta A, Tsunematu T, Kasukawa R, Mizusima Y, Kashiwagi H, Kashiwazaki S, Tanimoto K, Matsumoto Y, Ota T, Akizuki M: Preliminary criteria for classification of adult Still’s disease. J Rheumatol 1992;19:424–430.
5.
Bywaters EGL: Still’s disease in the adult. Ann Rheum Dis 1971;30:121–133.
6.
Rooney M, David J, Symons J, DiGiovine F, Varsani H, Woo P: Inflammatory cytokine responses in juvenile chronic arthritis. Br J Rheumatol 1995;34:454–460.
7.
Wakai K, Ohta A, Tamakosi A, Ohno Y, Kawamura T, Aoki R, Kojima M, Lin Y, Hasimoto S, Inaba Y, Minowa M, Aizawa S, Ichikawa Y, Miyasaka N: Estimated prevalence and incidence of adult Still’s disease: Findings by a nationwide epidemiological survey in Japan. J Epidemiol 1997;7:221–225.
8.
Ohta A, Yamaguchi M, Tsunematu T, Kasukawa R, Mizusima Y, Kashiwagi H, Kashiwazaki S, Tanimoto K, Matsumoto Y, Ota T, Akizuki M: Adult Still’s disease: A multicenter survey of Japanese patients. J Rheumatol 1990;17:1058–1063.
9.
Ishigaki M, Satake T: A fatal case of adult onset Still’s disease with lymph node histology simulating angioimmunoblastic lympadenopathy. Jpn J Clin Dermatol 1992;46:221–226.
10.
Mori K, Hamazaki Y, Ueki H, Ata Y, Yahata Y: A case of adult onset Still’s disease with thrombotic thrombocytopenic purpura. Jpn J Clin Dermatol 1993;103:513–520.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.